Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators

Details for Australian Patent Application No. 2008222755 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Searle, Lily Lee; Bignan, Gilles C.; Rentzeperis, Dionisios; Kim, Alexander; Gaul, Michael

Agent Shelston IP

Pub. Number AU-A-2008222755

PCT Pub. Number WO2008/109737

Priority 60/893,464 07.03.07 US

Filing date 6 March 2008

Wipo publication date 12 September 2008

International Classifications

C07D 277/34 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/109737 Priority application(s): WO2008/109737

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008222757-Transdermal analyte monitoring systems and methods for analyte detection

2008222753-O6-alkylguanine-DNA alkyltransferase inactivators